Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Percussionaire is a respiratory medical device company focused on specialty ventilation and airway-clearance technologies used across hospital, transport, emergency, and home-care settings. The company develops, manufactures, and markets products based on its Flow Ventilation and TRUE-IPV technology, including intrapulmonary percussive ventilation systems and related respiratory care devices. Percussionaire was founded in Idaho by respiratory-care pioneer Dr. Forrest Bird and built its manufacturing and R&D base in the Sandpoint, Idaho area. In September 2022, the company was acquired by Sentec, which positioned the business as a complement to its respiratory monitoring portfolio. Percussionaire appears to remain an operating brand and product business within Sentec, serving clinicians treating patients with compromised respiratory function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Percussionaire.